Journal: CytoJournal
Article Title: Transglutaminase 2 inhibition ameliorates cardiac fibrosis in myocardial infarction by inducing M2 macrophage polarization in vitro and in vivo
doi: 10.25259/Cytojournal_32_2024
Figure Lengend Snippet: Transglutaminase 2 downregulation transforming growth factor (TGF)-β1-induced myocardial fibrosis and repressed TGF-β1/small mother against decapentaplegic 3 (Smad3) pathway in mouse cardiac fibroblasts. (a and b) Small interfering negative control (si-NC) and siTransglutaminase 2 (si-TG2) were transfected to mouse cardiac fibroblasts isolated from C57BL/6 mice, and the protein expression of TG2 was detected through Western blot. (c-f) Mouse cardiac fibroblasts were treated with 100 µg/mL TGF-β1 to induce fibrosis, followed by transfection with siNC and si-TG2 for 48 h. Western blot was conducted to determine the levels of fibrosis-associated proteins, including collagen I, collagen III, and α-smooth muscle actin (α-SMA), in mouse cardiac fibroblasts after TGF-β1 treatment and transfection ( n = 3). (g-i) Western blot was also used in the assessment of the levels of TGF-β1, phospho-Smad3 (p-Smad3), and Smad3 in mouse cardiac fibroblasts after TGF-β1 treatment and transfection ( n = 3). (* P < 0.05. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.)
Article Snippet: The in vitro experiments involved the stimulation of cardiac fibroblasts with 100 µg/mL TGF-β1 (7754-BH, R and D Systems, Minneapolis, MN, USA) for 24 h to construct a myocardial fibrosis model. Next, the effects of knocking down TG2 on fibrosis were assessed using a myocardial fibrosis cell model. IL-4 (10 ng/mL, 404-ML; R and D Systems, Minneapolis, MN, USA) was used to interfere with bone marrow-derived macrophages (BMDMs) for 24 h to induce macrophage polarization.
Techniques: Negative Control, Transfection, Isolation, Expressing, Western Blot